Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003002
Status:
COMPLETED
Last Update Posted:
2019-02-27
First Post:
1999-11-01
Brief Title:
HER-2Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast Ovarian or Non-small Cell Lung Cancer
Sponsor:
University of Washington
Organization:
University of Washington
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Ovarian Cancer |
| Breast Cancer |
| Lung Cancer |